Villalona Calero, M., Patnaik, A., Maki, R., O’Neil, B., Abbruzzese, J., Dagogo-Jack, I., … Ahnert, J. (2022). EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. In Journal of Thoracic Oncology (Vol. 17, pp. S457–S457). Elsevier BV. https://doi.org/10.1016/j.jtho.2022.07.799

Villalona Calero, M., A. Patnaik, R. Maki, B. O’Neil, J. Abbruzzese, I. Dagogo-Jack, S. Devarakonda, et al. “EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors.” In Journal of Thoracic Oncology, 17:S457–S457. Elsevier BV, 2022. https://doi.org/10.1016/j.jtho.2022.07.799.

Villalona Calero M, Patnaik A, Maki R, O’Neil B, Abbruzzese J, Dagogo-Jack I, et al. EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. In: Journal of Thoracic Oncology. Elsevier BV; 2022. p. S457–S457.

Villalona Calero, M., et al. “EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors.” Journal of Thoracic Oncology, vol. 17, no. 9, Elsevier BV, 2022, pp. S457–S457. Crossref, doi:10.1016/j.jtho.2022.07.799.

Villalona Calero M, Patnaik A, Maki R, O’Neil B, Abbruzzese J, Dagogo-Jack I, Devarakonda S, Wahlroos S, Lin C-C, Fujiwara Y, Terbuch A, Postel-Vinay S, Goebeler M-E, Addeo A, Prenen H, Arkenau T, Sacher A, Liu C, Kormany W, Ahnert J. EP08.02-116 Design of a Phase 1 Study of AMG 193, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced MTAP-Null Solid Tumors. Journal of Thoracic Oncology. Elsevier BV; 2022. p. S457–S457.